| Ms Holly Eun Hee Gangwer, SLP | |
|
Psc 561 Box 1877, Fpo, AP 96310 | |
| (011) 827-794180 | |
| Not Available |
| Full Name | Ms Holly Eun Hee Gangwer |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Psc 561 Box 1877, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043281132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP 6033 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Holly Eun Hee Gangwer, SLP Psc 561 Box 1877, Fpo, AP 96310 Ph: (011) 827-794180 | Ms Holly Eun Hee Gangwer, SLP Psc 561 Box 1877, Fpo, AP 96310 Ph: (011) 827-794180 |
News Archive
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.
An international, multidisciplinary research team from more than 50 institutions, led by geneticist and psychiatrist Gholson Lyon, MD, PhD, of the New York State Office for People With Developmental Disabilities' Institute for Basic Research in Developmental Disabilities, today announced publication of findings from its study of the rare disease TAF1 syndrome.
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
Palatin Technologies, Inc. (NYSE Amex: PTN) today announced results for its fourth quarter and fiscal year ended June 30, 2009. For the year ended June 30, 2009, total revenues were $11.4 million, compared to $11.5 million for year ended June 30, 2008. Palatin's net loss for the year ended June 30, 2009 was $4.8 million, or $(0.06) per basic and diluted share, compared to a net loss of $14.4 million, or $(0.17) per basic and diluted share, for the year ended June 30, 2008.
To increase patient safety in clinical practice and minimize risks and damage that may arise during surgery, computer support and digital medical imaging are key technologies. Before brain operations, neurosurgeons can now evaluate patient-specific surgical risks, achieve increased safety, and avoid unacceptable risks.
› Verified 9 days ago
Kati Conners, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Fpo, AP 96362 Phone: 334-819-9511 | |
Mrs. Kristin Rachel Blake, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482 Box 1600, Fpo, AP 96367 Phone: 011-816-117342747 | |
Mrs. Paige Christine Potter, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6162d- Camp Lester, Fpo, AP 96362 Phone: 011-816-117468093 | |
Barbara Jean Neal, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Usnh Yokosuka Japan, Psc 475 Box 1, Fpo, AP 96350 Phone: 011-814-68165564 Fax: 011-814-68168650 | |
Ms. Edna E. Nyang, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Fpo, AP 96362 Phone: 611-646-7723 | |
Kimberly Lowery, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 215-264-3402 |